Disc Medicine Files 8-K with Financials and Exhibits
Ticker: IRON · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1816736
| Field | Detail |
|---|---|
| Company | Disc Medicine, Inc. (IRON) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, corporate-update
TL;DR
Disc Medicine filed an 8-K on Jan 21, 2025, mostly financials & exhibits. Formerly Gemini Therapeutics.
AI Summary
On January 21, 2025, Disc Medicine, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and other events. Disc Medicine, Inc. was formerly known as Gemini Therapeutics, Inc. and FS Development Corp.
Why It Matters
This filing provides updated financial information and details on other corporate events for Disc Medicine, Inc., which is crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting financial statements and exhibits, with no immediate indication of significant new risks or material adverse events.
Key Numbers
- 001-39438 — SEC File Number (Disc Medicine's SEC registration identifier.)
- 85-1612845 — IRS Employer Identification No. (Disc Medicine's tax identification number.)
Key Players & Entities
- Disc Medicine, Inc. (company) — Registrant
- Gemini Therapeutics, Inc. (company) — Former company name
- FS Development Corp. (company) — Former company name
- 0001193125-25-009095 (filing_id) — Accession Number
- 20250121 (date) — Filing date
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report financial statements and exhibits, as well as other events, for Disc Medicine, Inc.
When was this 8-K report filed?
This 8-K report was filed on January 21, 2025.
What were Disc Medicine, Inc.'s former names?
Disc Medicine, Inc. was formerly known as Gemini Therapeutics, Inc. and FS Development Corp.
In which state is Disc Medicine, Inc. incorporated?
Disc Medicine, Inc. is incorporated in Delaware.
What is the principal executive office address for Disc Medicine, Inc.?
The principal executive office address for Disc Medicine, Inc. is 321 Arsenal Street, Suite 101, Watertown, Massachusetts 02472.
Filing Stats: 1,289 words · 5 min read · ~4 pages · Grade level 13.8 · Accepted 2025-01-21 07:52:48
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share IRON The Nasdaq Global Ma
Filing Documents
- d858127d8k.htm (8-K) — 35KB
- d858127dex991.htm (EX-99.1) — 20KB
- g858127imag0001.jpg (GRAPHIC) — 10KB
- 0001193125-25-009095.txt ( ) — 198KB
- iron-20250121.xsd (EX-101.SCH) — 3KB
- iron-20250121_lab.xml (EX-101.LAB) — 18KB
- iron-20250121_pre.xml (EX-101.PRE) — 11KB
- d858127d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Disc Medicine, Inc. on January 21, 2025, furnished herewith 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISC MEDICINE, INC. Date: January 21, 2025 By: /s/ John Quisel, J.D., Ph.D. Name: Title: John Quisel, J.D., Ph.D. Chief Executive Officer